# Boehringer Ingelheim Fremont, Inc., Fremont, CA – FDA Inspections

Source: https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861

> Inspection records and compliance data for Boehringer Ingelheim Fremont, Inc. in Fremont, California. 8 FDA inspections on record, 3 Form 483s, last inspected May 16, 2024.

---

## Details

- Name: Boehringer Ingelheim Fremont, Inc.
- FEI Number: 3005925062
- Address Line 1: 6701 Kaiser Dr
- City: Fremont
- State: California
- Zip Code: 94555
- Country Name: United States
- Address: 6701 Kaiser Dr, Fremont, California 94555, United States
- Country: United States

## Related Documents

- [FDA Inspection 1263388 - Boehringer Ingelheim Fremont, Inc. - 2024-05-16](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/ce7fd041-d5df-4734-84bf-8c8491fceee4) — source: FDA, date: May 16, 2024
- [EIR - Boehringer Ingelheim Fremont, Inc. - 2023-04-13](https://www.keypedia.com/records/eir/boehringer-ingelheim-fremont-inc/66f1beae-6b38-4ab2-b49c-b4e935efddf3) — source: FDA, date: April 13, 2023
- FDA Inspection 1205076 - Boehringer Ingelheim Fremont, Inc. - 2023-04-13 — source: FDA, date: April 13, 2023
- [EIR - Boehringer Ingelheim Fremont, Inc. - 2022-11-04](https://www.keypedia.com/records/eir/boehringer-ingelheim-fremont-inc/0e786b24-7b4c-473a-9dec-73907b1b122d) — source: FDA, date: November 4, 2022
- [483 - Boehringer Ingelheim Fremont, Inc. - 2022-11-04](https://www.keypedia.com/records/483/boehringer-ingelheim-fremont-inc/9e6e4169-d682-4b30-8ddd-4857a586bbf4) — source: FDA, date: November 4, 2022
- [FDA Inspection 1187410 - Boehringer Ingelheim Fremont, Inc. - 2022-11-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/817f2419-ae3e-4fdf-b387-b7551f09fb7e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 4, 2022
- [483 - Boehringer Ingelheim Fremont, Inc. - 2018-08-24](https://www.keypedia.com/records/483/boehringer-ingelheim-fremont-inc/eaf43242-79af-4cd0-b066-41ff35c67a2d) — source: FDA, date: August 24, 2018
- FDA Inspection 1063730 - Boehringer Ingelheim Fremont, Inc. - 2018-08-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2018
- [FDA Inspection 1063730 - Boehringer Ingelheim Fremont, Inc. - 2018-08-24](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/fe8b0eff-9aee-4c03-a4e1-cee8ba3aae35) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2018
- [483 - Boehringer Ingelheim Fremont, Inc. - 2017-04-04](https://www.keypedia.com/records/483/boehringer-ingelheim-fremont-inc/22dda148-a183-4658-941d-070cff867701) — source: FDA, date: April 4, 2017
- [FDA Inspection 1005958 - Boehringer Ingelheim Fremont, Inc. - 2017-04-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/ff7cd87f-90a8-4b66-8652-6004f0512e9e) — source: FDA, date: April 4, 2017
- FDA Inspection 882791 - Boehringer Ingelheim Fremont, Inc. - 2014-05-28 — classification: No Action Indicated (NAI), source: FDA, date: May 28, 2014
- [FDA Inspection 793286 - Boehringer Ingelheim Fremont, Inc. - 2012-08-07](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/d47d7eef-f25c-402c-ab9e-3c4ce6a8b80f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 7, 2012
- [FDA Inspection 653544 - Boehringer Ingelheim Fremont, Inc. - 2010-02-25](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/b12233de-a157-49d1-9735-de1d79f08060) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 25, 2010

## Related Companies

- [Amgen Manufacturing Ltd](https://www.keypedia.com/companies/amgen-manufacturing-ltd/cecb788c-4cd6-4c26-9331-7b68b4f12369)
- [Biological E. Limited](https://www.keypedia.com/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)
- [Qilu Antibiotics Pharmaceutical Co. , Ltd.](https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c)
- [Fujian Genohope Biotech Ltd.](https://www.keypedia.com/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [BioMarin International Limited](https://www.keypedia.com/companies/biomarin-international-limited/dbd5911b-3dec-4a03-a980-1e45a5f973a4)
- [Pharmaron (Ningbo) Technology Development Co., Ltd.](https://www.keypedia.com/companies/pharmaron-ningbo-technology-development-co-ltd/c40334bd-b474-48eb-91c6-51a228da2a42)
- [Cipla, Ltd.](https://www.keypedia.com/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f)
- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)

## Related Officers

- [investigator](https://www.keypedia.com/people/ephrem-hunde/3c582fce-ff16-49e8-9594-34d19b7c524e)
- [Richard Ledwidge](https://www.keypedia.com/people/richard-ledwidge/aaf4f089-8f7a-4d1f-b2e1-5f2e476a22a9)
- [Senior Consumer Safety Officer ](https://www.keypedia.com/people/marcus-f-yambot/a2266014-ae7e-4d64-aeba-a8cfb873f100)
- [Compliance Officer - CDER/OC/OMQ](https://www.keypedia.com/people/anita-narula/fbebf5a2-e25c-4e98-9c22-433d9102380c)
- [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)
- [Consumer Safety Officer](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)